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Fluorescence Correlation Spectroscopy (FCS) is used to study the interaction of a recently designed antimicrobial peptide, called V4, with LPS
and lipids of varying head and tail groups. V4 is designed based on a known amphipathic cationic pattern BHPHB (B: basic; H: hydrophobic; P:
polar residue, respectively) and shows a good combination of high antimicrobial activity, low cytotoxic activity and low hemolytic activity. It is
shown that V4 has high binding affinity for LPS, which is the major component of the outer membrane of Gram-negative bacteria, and shows
selectivity for negatively charged lipids in contrast to zwitterionic lipids at a low peptide/lipid ratio. At high peptide/lipid ratio, V4 can
permeabilize vesicles composed of negatively charged lipids and eventually cause vesicle fusion. The identification of the amphipathic cationic
pattern as the mediator of selectivity and antimicrobial activity could be a first step in the rational design of better antimicrobial peptides.
D 2005 Elsevier B.V. All rights reserved.Keywords: Antimicrobial peptide; Fluorescence correlation spectroscopy1. Introduction
Antibiotics are widely used for therapy of bacterial
infection. However, extensive clinical use of antibiotics has
caused an increase in antibiotic resistance, which makes it
necessary to look for and develop new drugs [1–3]. Emerging
potent candidates are antimicrobial peptides which are found in
different organisms including insects, amphibians and mam-0005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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Abbreviations: V4, CVKVQVKVGSGVKVQVKVC; Rho 6G, Rhodamine
6G chloride; TMR, tetramethylrhodamine; R18, octadecyl rhodamine B
chloride; LPS, lipo-polysaccharide; FITC-LPS, fluorescein isothiocyanate
lipopolysaccharide; PBS, Phosphate buffered saline; PC, Phosphatidylcholine;
DPPC, 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine; DPPE, 1,2-Dipalmitoyl-
sn-Glycero-3-Phosphoethanolamine; DPPG, 1,2-Dipalmitoyl-sn-Glycero-3-[Phos-
pho-rac-(1-glycerol)]; POPC, 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine;
POPE, 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phospho-ethanolamine; POPG, 1-Pal-
mitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)]; Rho-PE, 1,2-Dipalmi-
toyl-sn-Glycero-3-Phospho-ethanolamine-N-(Lissamine Rhodamine B Sulfonyl)
(Ammonium Salt)
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E-mail address: chmwt@nus.edu.sg (T. Wohland).mals [4–7] and which play a major role in the host defense
against microbial infection. Based on their structure, antimi-
crobial peptides can be divided into three main groups: a-helix,
h-sheet and peptides rich in certain amino acid residues [8].
The a-helical conformation which is adopted by most linear
antimicrobial peptides is usually induced when these peptides
are in a hydrophobic environment such as a membrane, in lipid
or detergent. The well-known insect cecropins [9] and frog
magainins [4] belong to this group. Antimicrobial peptides
with a h-sheet conformation usually possess disulfide bonds
which are used to stabilize the conformation. Examples of this
group include mammalian defensins [10,11] and protegrins
[12,13]. The third group of antimicrobial peptides is mainly
composed of certain specific amino acids. For example, the
peptide tritrpticin [14] and indolicidin [15] are both rich in
tryptophan and histatin is rich in histidine [16,17].
Antimicrobial peptides are thought to interact with lipopo-
lysaccharides (LPS) which form a major part of the bacterial
outer membrane in Gram-negative bacteria. LPS which is
negatively charged is composed of three parts: O-antigen,ta 1716 (2005) 29 – 39
http://www
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component of LPS which is responsible for most of the
endotoxic effects. It has been shown that lipid A is the main
interacting partner with antimicrobial peptides [18]. Using
antimicrobial peptides to neutralize LPS, especially lipid A, is
believed to be an effective approach to kill bacteria.
Although more than 800 antimicrobial peptides have been
identified in eukaryotes (http://www.bbcm.units.it/~tossi/
amsdb.html, Antimicrobial Sequences Database), these peptides
are usually not fit for medical use due to their cytotoxic and
hemolytic effects. There is therefore a need to design novel
antimicrobial peptides with low cytotoxicity and low hemolytic
activity. One strategy followed is the identification of the LPS
binding domains on selected antimicrobial peptides and the
design of new peptides containing these binding sites. Screening
for high antibacterial activity, low cytotoxicity and low hemolytic
activity can then be used for selection of potential drug candidates.
It has been well known that most natural antimicrobial
peptides are net positively charged and also harbor some hydro-
phobic amino acid residues in spite of considerable variation in
their primary structure and length [19]. Known peptide struc-
tures and computational models show an amphipathic cationic
pattern BHPHB (B: basic; H: hydrophobic; P: polar residue,
respectively) as a possible binding site of antimicrobial peptides
to LPS [18]. Based on this pattern, a series of peptides have been
designed and it was shown that amongst these, a peptide named
V4 is prominent. V4 has a good combination of high
antimicrobial activity, low cytotoxic activity and low hemolytic
activity compared to other designed and natural peptides [20].
In the present work, we used fluorescence correlation
spectroscopy (FCS) to investigate the interaction of this novel
artificial peptide V4 with different membrane components. FCS
is a technique that has been developed more than 30 years ago
and relies on the measurement of fluorescence from a small,
femtoliter size confocal volume [21]. A statistical analysis of the
fluctuations in the fluorescence signal via an autocorrelation
function yields information about the molecular processes
underlying these fluctuations. The potential of FCS has been
described in many recent reviews [22–26]. In biophysical
applications in particular, FCS gives information, about con-
centration, binding, and aggregation of different components in
a sample. In particular, FCS has been used to study the inter-
action of peptides with lipids [27,28]. In this study we use these
capabilities of FCS to (i) obtain information about the oligo-
merization or aggregation state of V4, (ii) compare the affinity of
binding of V4 for different lipid components of mammalian and
microbial membranes and (iii) examine the influence of V4 on
the integrity of lipid bilayers of different composition. From the
data, we have gained insights into the possible mechanisms of
action of V4 and can obtain suggestions on how to improve on
the design of artificial antimicrobial peptides.
2. Materials and methods
2.1. Materials
Rhodamine 6G chloride (Rho 6G), tetramethylrhodamine (TMR) and
octadecyl rhodamine B chloride (R18) are products from Molecular Probes(ITS Science and Medical Pte Ltd., Singapore). Lipopolysaccharide from
Escherichia coli strain 0111:B4 (LPS), its fluorescent derivative fluorescein
isothiocyanate lipopolysaccharide (FITC-LPS), Lipid A from Escherichia coli
strain F583, Triton-X100 and Phosphate buffered saline (PBS) were
purchased from Sigma-Aldrich (Sigma-Aldrich Pte Ltd., Singapore). DMSO
was purchased from Mallinckrodt Baker (Mallinckrodt Asia Pacific Pte. Ltd.,
Singapore). Phosphatidylcholine (PC), 1,2-Dipalmitoyl-sn-Glycero-3-Phos-
phocholine (DPPC), 1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine
(DPPE), 1,2-Dipalmitoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (DPPG),
1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC), 1-Palmitoyl-2-
Oleoyl-sn-Glycero-3-Phosphoethanolamine (POPE) and 1-Palmitoyl-2-
Oleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (POPG), 1,2-Dipalmitoyl-sn-
Glycero-3-Phospho-ethanolamine-N-(Lissamine Rhodamine B Sulfonyl) (Am-
monium Salt) (Rho-PE) were purchased from Avanti (Avanti Polar Lipids,
Inc., Alabaster, AL).
2.2. Peptides
The sequence of V4 is CVKVQVKVGSGVKVQVKVC with cyclization by
a disulfide bond at the two terminal cysteines (C). Four lysine (K) residues
provide high net positive charge and eight valine (V) residues make this peptide
highly hydrophobic. V4-TMR is the V4 labeled with TMR at the N-terminus.
Both peptides were synthesized by Genemed (Genemed Synthesis, Inc., South
San Francisco, CA). According to the HPLC data provided by the company, the
purity of V4-TMR is about 84% and the purity of V4 is above 97%. The stock
solution of V4-TMR peptide was prepared as a 2-mM solution in DMSO. The
stock solution of V4 was prepared as 1 mM in water. Both stock solutions were
stored at 20 -C in small aliquots until further use.
2.3. Small unilamellar vesicles (SUVs) preparation
All lipids were prepared as stock solutions in chloroform or a mixture of
chloroform and ethanol (4:1). The solvent was evaporated under N2 gas and
then the samples were placed into vacuum for at least 1 h. PBS buffer, pH 7.4,
was added to re-dissolve the lipids to give an aqueous suspension of
phospholipids at a concentration of 0.5 mM. SUVs were prepared by
freeze– thawing the lipid suspension 5 times followed by extrusion through
0.05 Am polycarbonate membrane filters 20 times using a mini-extruder syringe
device (Avanti Polar Lipids). The extruded lipid solutions were diluted and
mixed with 200 nM V4-TMR to study the interaction of peptide and lipid
vesicles by FCS.
2.4. Fluorophore entrapped vesicle preparation
The preparation followed a similar protocol as for LUVs. After removing
the solvent from the lipids, PBS including Rho 6G was added to prepare
suspensions of phospholipids. After 5 freeze– thaw cycles the suspension was
extruded through 0.1 Am membranes. MicroSpini S-200 HR Columns
(Amersham Biosciences, Singapore) were used to remove non-entrapped Rho
6G from the vesicle solution [27].
2.5. Fluorophore labeled vesicle preparation
Confocal imaging was taken with LUVs which were labeled with 1% Rho-
PE. Fluorophore labeled vesicles were prepared by mixing POPG with a
content of 1% Rho-PE in chloroform. After removing the solvent completely,
PBS was added to make a suspension of phospholipids. The fluorophore
labeled LUVs were obtained by freeze– thawing lipid suspension 5 times
followed by extrusion 20 times through 0.1 Am polycarbonate membrane
filters.
2.6. Fluorescence correlation spectroscopy (FCS)
FCS is a biophysical technique with single molecule sensitivity. It analyzes
fluorescence intensity fluctuations caused by minute deviations from thermal
equilibrium from a confocal volume in a sample which contains fluorescent
particles [21,24,29,30]. For 3D diffusion processes, including a possible triplet
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N is the average number of particles in the confocal volume and c is a
correction factor for the photon count rates distribution in the confocal
volume [22,31–33]. The factor c is a constant correction factor and we
neglect it in further equations. To recover absolute concentrations we
calibrated the system with a 1-nM fluorophore solution and set all other
values in relation to this calibration. The fluorescence yields Qi are the
product of the extinction coefficient, the quantum yield, and the overall
detection efficiency for particle i in the instrument. The coefficients Fi are
the mole fraction of species i in the sample and gi (s) is the characteristic
function of the underlying process that causes the fluctuations. Ti is the
average fraction of particles of species i that reside in the triplet state and
sTi is the relaxation time due to the transition of the dye between the
ground state and the first excited singlet and triplet state [40]. sDi is the
lateral diffusion time of the fluorescent particle staying in the confocal
volume. Di is the diffusion coefficient of species i, and x and z are the
radial and axial distances of the confocal volume at which the photon
count rates has dropped by 1/e2 of the maximum value. GV is the
convergence value of the ACF for long times, in general this value is 1.
The program IgorPro (Wavemetrics, Lake Oswego, OR, USA) was used for
fitting of the autocorrelation function to experimental data as described
previously [34].
The fluorescence yields Qi are important parameters in FCS. They
determine the signal to noise ratio [35] but are as well a characteristic value
for a fluorophore in a certain environment. Therefore, determining the value
of Q of a particle can yield information which can help identify a
fluorophore and can give information about the local environment of the
fluorophore. For a solution with a single fluorophore present and negligible
background it is simply given by the number of average photon count rates,
C1, divided by the average number of particles in the confocal volume, N1
as obtained from the ACF.
Q1 ¼ C1
N1
ð4Þ
In solutions with two different fluorophores and photon count rates C12, the
autocorrelation amplitude which is inversely proportional to the apparent
number of particles Napp is given by (Eq. (1) with i =2):
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In this case, the values of Q can in general not be unambiguously determined if
the concentration of the second species is not known. However, in the case that
the number of particles N1 and the fluorescence yield Q1 for one of the
fluorophores is known, e.g. if a fluorescent species of constant concentration ispresent in the samples, then F2 (note that F2=1F1) and Q2/Q1 can be
calculated from Eqs. (4)– (6):
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The values thus obtained can then be used to identify the second particle or
make predictions of its environment. This method was used to calculate the
fluorescence yield and concentration of lipid-bound V4-TMR in the presence of
a constant fluorescent impurity with known fluorescence yield, assumed to be
free TMR.
In this work, all values have been corrected for background photon
count rates [35,36] and refer to the uncorrected values for the number of
particles as Nmeas and to the corrected values as Nc. B is the photon
count rates of background which in this work is referred to the photon
count rates of PBS solution. The number of particles is corrected by the
Eq. (9).
Nc ¼ Nmeas  bF
bF þ B2
ð9Þ
If one fluorescent species is present, Nc is N. If two fluorescent species are
present, then Nmeas is used to describe the inverse of the amplitude, Napp is
the background corrected value Nc (Eq. (5)), N is the number of particles
corrected for background and different fluorescence yields, and F2 describes
the mole fraction of the second species.
2.7. FCS instrumentation
FCS experiments were performed using an Axiovert 200 inverted
microscope (Carl Zeiss South East Asia, Singapore). The laser was focused
on the samples using a water immersion objective (C-Apochromat, 63, NA
1.2, Zeiss). A dichroic filter (560DRLP, Omega, microLAMBDA Pte Ltd.,
Singapore) and an emitter (595AF60, Omega) were used to separate the
excitation light from the emission fluorescence. The samples were excited
with the 530-nm line of laser beam from an Argon-Krypton laser (Melles
Griot SP, Pte Ltd., Singapore). A 50 Am diameter pinhole (Wilson
Engineering (S) Pte Ltd., Singapore) in the image plane blocked out-of-
focus signals. The emitted fluorescence was detected by an avalanche photo
diode (PerkinElmer Canada Inc., Canada) detector and then the signals were
sent to a digital correlator (Model: Flex02-12D, http://www.correlator.com) to
be autocorrelated.
2.8. Interaction of V4 with R18
200 nM unlabeled V4 was titrated by 10 nM R18 in PBS buffer. FCS
experiments were performed at room temperature.
2.9. Interaction of V4-TMR with LPS
The stock solution of V4-TMR in DMSO (2 mM) was diluted with PBS
to 100 nM. LPS was dissolved in PBS to different concentrations (50, 100,
150, 200, 300, 400, 500, 600, 700, 1000, 2000 and 10,000 nM). The
mixture of peptide and different concentrations of LPS were incubated for
at least 4 h to reach equilibrium. FCS experiments were performed at room
temperature.
2.10. Interaction of V4 with FITC-LPS
500 nM FITC-LPS and different concentrations of V4 (10 nM, 100 nM,
1 AM) were mixed followed by at least 4 h incubation. FCS measurements were
performed using the 488 nm Argon-Krypton laser line for excitation at a power
Fig. 1. The amphipathic dye R18 incorporates into V4 aggregates. (A
Autocorrelation function of 200 nM unlabeled V4 in presence of 10 nM R18
The solid line is the fit to the data depicted in grey. Nmeas=1.669; sD1=54.4 As
sD2=31.0 ms. (B) Photon count rates trace of V4 with R18.
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bandpass filter (530DF30).
2.11. Interaction of V4-TMR with lipid A and PC
Lipid A and PC were dissolved in PBS respectively and diluted to 10 AM.
The mixture of V4-TMR and lipid A or PC was incubated for at least 4 h for
FCS experiments.
2.12. Interaction of V4-TMR with SUVs
The procedure is similar to that of interaction of V4-TMR with LPS. The
SUVs solutions with different lipid compositions were diluted to 50 AM (lipid
concentration) and incubated with 200 nM V4-TMR for at least 4 h followed by
FCS experiments.
2.13. Interaction of V4 with fluorophore entrapped LUVs
The stock solution of fluorophore entrapped LUVs was diluted to 20 AM
(lipid concentration). 10 AM V4 was added into the above solution. The FCS
experiments were performed by mixing the peptide and LUVs solutions in situ.
2.14. Fluorescence confocal imaging
Studies of V4-TMR attachment on glass coverslips and of the effect of V4
on fluorophore labeled LUVs were performed with a confocal microscope
(FluoViewi FV300, Olympus, Singapore), equipped with a HeNe laser (543
nm) for excitation, a water-immersion objective (UPlanApo, 60, NA1.2,
Olympus) and a long pass emission filter at 560 nm. In the study of attachment
of V4-TMR on glass coverslips (0.17 mm thick, Fisher Scientific Pte Ltd.,
Singapore), a PBS solution with either 100 nM TMR, 5 AM V4-TMR or 5 AM
V4-TMR with 50 AM LPS were placed on the coverslilp and a stack of 60
confocal images of each solution were acquired from 15 Am below coverslip to
45 Am above coverslip with a step size of 1 Am. The average fluorescence
intensity of each confocal image was calculated and the values for the surface
and solution were reported.
For the study of the action of V4 on fluorescently labeled LUVs, the stock
solution of 1% fluorescently labeled LUVs was diluted to 20 AM (lipid
concentration) and placed on a coverslip. A stack of 20 confocal images was
acquired from bottom to top with a step size of 1 Am. After addition of 10 AM
V4 the same procedure was followed.
3. Results
3.1. Calibration of the FCS setup
The FCS setup was first calibrated with a 1-nM solution of
TMR in PBS. Measurements were performed in 6 replicates
and fitted with a one-particle model. The laser power was set to
100 AW before entering the microscope. The background
photon count rates of PBS buffer were 0.9 kHz. The average
number of particles measured was Nmeas=0.388T0.006 and the
average diffusion times was sD=56.9T0.8 As. After back-
ground correction the number of particle was N =0.349 and
fluorescence yield Q was calculated to be 51.6 kHz (Eq. (4)).
The structure factor was K =4.6T0.4, and the convergence
value for long correlation times was GV=1.000T0.001. In all
other measurements K was fixed and GV was always close to 1
and will not be further discussed in this work. The diffusion
time of micellar LPS was identified to be 1.77T0.50 ms by
using FITC-LPS. The diffusion time of lipid SUVs was
determined to be in the range of 1.3 to 3.5 ms by labeling
with the amphipathic dye R18.3.2. Solubility of V4-TMR
First the solubility was tested in PBS buffer. For V4-TMR
solutions of 1 nM the photon count rates were at background
level and no correlations could be detected. We have
subsequently chosen concentrations of 100–200 nM of V4-
TMR for FCS measurements. At a concentration of 100 nM
the average number of particles measured was Nmeas =
0.098T0.004. There was one species in the solution with
sD=52.5T1.8 As. After background correction the number of
particle was N =0.064 and Q was determined to be 59.5 kHz.
Because of the similar sD and Q of V4-TMR and of free TMR,
it is likely that the measured particles correspond to free TMR
and represent an impurity. Only on rare occasions some strong
peaks could be observed in the photon count traces. A two-
particle model had to be used in those cases where the second
particle had a fraction usually smaller than 10% and a strongly
variable sD of 684T440 As. These peaks might point towards
peptide aggregation.
To test for peptide aggregation in PBS, unlabeled V4
solutions were titrated with the amphipathic dye R18. In
these experiments, large aggregates were detected as shown
by the large sDs and distinct peaks in the photon count
traces (Fig. 1). The diffusion time distribution of aggregates
was quite wide, ranging from several hundreds of micro-
seconds to tens of milliseconds. These experiments indicate
that V4-TMR is aggregated and the fluorescence is strongly
quenched. Therefore we tried to dissolve V4-TMR in
different solvents. Due to the hydrophobic and positively
charged characteristic of V4, we tried DMSO as well as the)
.
;
Fig. 3. Autocorrelation functions of 100 nM V4-TMR with different
concentrations of LPS in PBS. With increasing concentrations of LPS (100–
2000 nM), the amplitude of the autocorrelation function decreased as indicated
by the arrow and a longer diffusion time (sD2=1.36T0.17 ms) with a constantly
increasing fraction appeared (for the fraction see Fig. 4). Fits to the data are
given as solid lines.
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alternatively pure de-ionized water to minimize ions that
could shield the positive charges and facilitate aggregation
(Fig. 2).
In PBS, 200 nM V4-TMR yielded an Nmeas of 0.182T
0.008. In Triton-X100, at the same V4-TMR concentration
Nmeas was 5.167T0.737, which is an increase of a factor 28.
A two-particle model was used to fit the data and besides a
fast species with 53.7T1.0 As, which is assumed to be free
TMR, a slow species was detected with sD=317T47 As.
In de-ionized water Nmeas was 0.635T0.076 which is an
increase of a factor 3.5 compared to PBS solutions. In this case,
V4-TMR solutions also showed two sDs, one again similar to
free TMR and the other 447T30 As.
In DMSO strong quenching was observed and the measured
number (compared to a calibration with 1 nM Rho 6G in
DMSO) rose by a factor 2.1. Although an increase in Nmeas can
be observed in the different solvents, the value of Nmeas always
remained below the expected value by almost a factor 20 in the
best case (Triton-X100). This is also supported by NMR
measurement of V4-TMR which showed broadened peaks
indicating peptide aggregation (data not shown). In the rest of
the work, experiments have been performed in PBS solution
since it is physiologically the most relevant condition.
3.3. Binding of V4-TMR to LPS
The putative target molecule for antimicrobial peptides in
the outer membrane of bacteria is LPS [37]. Therefore, at a
concentration of 100 nM V4-TMR, increasing concentrations
of LPS were added to test for binding activity. The dependence
of the ACF on the concentration of LPS is shown in Fig. 3.
Two components can be distinguished in solution, a fast
diffusing species (fixed at sD1=52 As) and an average slow
diffusing species (sD2=1.36T0.17 ms) with a diffusion time
similar to that of LPS micelles (sD=1.77T0.50 ms). WithFig. 2. Autocorrelation function of 200 nM V4-TMR in PBS, water
and 0.05% Triton-X100. The measured particle numbers are as follows:
NV4-TMRPBS=0.182T0.008, sD1=56.7T0.5 As, sD2=684T440 As; NV4-TMRwater=
0.635T0.076, sD1=54 As (fixed), sD2=447T30 As; NV4-TMRTriton-X100 =
5.167T0.737, sD1=54 As (fixed), sD2=317T47 As.increasing concentrations of LPS, the amplitude of the ACF
decreased continuously, indicating an increasing number of
fluorescent particles in the confocal volume. At the same time,
the overall photon count rates increased synchronously with the
apparent number Napp (Fig. 4A). In controls of TMR/LPS
mixtures, no change in amplitude or intensity could be
observed.
Assuming that the fast diffusing species corresponds to a
constant impurity of free TMR, the fluorescence yield Q2 of
the slower diffusing species can be obtained (Eq. (7)). Napp and
C12 are obtained directly from measuring mixtures of V4-TMR
and LPS after background correction. N1 and C1 are
determined from V4-TMR solution assuming that only free
TMR was detected and aggregates are mostly quenched. The
V4-TMR: LPS complex is 1.73T0.28 times as bright as free
TMR. The fluorescence yield Q2 of V4-TMR: LPS is
calculated to be 102.9 kHz. The fraction F2 and number of
V4-TMR: LPS complexes N2 in the confocal volume are
plotted in Fig. 4B and C in dependence on the LPS
concentration (see Eq. (8)). Both, F2 and N2 rise with
increasing LPS concentrations up to F2=80% and N2=0.27
at an LPS concentration of 2 AM after which these values stay
constant.
3.4. Binding of unlabeled V4 to FITC-LPS
At a FITC-LPS concentration of 500 nM and unlabeled V4
concentrations between 10 nM and 1 AM, no change in sD or N
were seen.
3.5. Attachment on the coverslip surface
Because of the hydrophobicity of V4-TMR, the effect of
glass coverslips on V4-TMR was investigated by taking
confocal images of the surface and the solution and
calculating their respective average fluorescence intensities
(Table 1).
Table 1
Comparison of TMR, V4-TMR, V4-TMR: LPS on coverslip
Intensity on
surface [AU]
Intensity in
solution [AU
PBS 1.37T9.50 0.40T0.02
100 nM TMR 3432T682 423T5
5 AM V4-TMR 306T220 23T2
5 AM V4-TMR:
50 AM LPS
1511T455 727T3
Fig. 4. Titration of 100 nM V4-TMR with increasing concentrations of LPS (50
nM–10 AM). (A) Photon count rates and apparent number of particles in the
confocal volume in dependence on LPS concentrations. (B) The mole fraction
F2 in the solution increased with increasing concentrations of LPS and reached
saturation around 80%. (C) The number of V4-TMR: LPS complexes N2 in the
confocal volume increased with the increasing concentrations of LPS. Solid
lines are added to guide the eye.
Fig. 5. Comparison of autocorrelation functions of V4-TMR and the complexes
of V4-TMR with LPS, lipid A and PC. The concentration of V4-TMR was 100
nM; the concentrations of LPS, lipid A and PC were 10 AM. Fits to the data are
given in solid lines.
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Upon addition of V4-TMR to LPS, lipid A, and PC, the
ACF changed significantly with the different binding process-
es. Fig. 5 shows the autocorrelation function of 100 nM V4-
TMR mixed with 10 AM LPS, lipid A or PC. A concentration
of 10 AM was chosen since at this level binding of V4-TMR to
LPS was saturated as shown in the previous experiment. The
detailed data are given in Table 2. The mixture of V4-TMR
with PC showed similar ACFs and photon count rates as V4-]TMR. Assuming again the first particle to be an impurity of
free TMR, a two-particle model was used for data fitting. The
second particle exhibited an F2 of 4.2% and an increase in the
fluorescence yield compared to TMR of Q2/Q1 of 3.21.
However, the V4-TMR: LPS and V4-TMR: lipid A
mixtures showed stronger changes in the ACFs. The apparent
number of particles in these solutions increased to 0.324 for
LPS and 0.095 for lipid A. Concomitantly, an increase in the
overall photon count rates was observed, yielding 30.8 kHz and
11.2 kHz for the LPS and lipid A solutions, respectively. The
fluorescence yield of the V4-TMR: LPS and V4-TMR: lipid A
complexes compared to TMR was Q2/Q12. Both, V4-TMR:
LPS, V4-TMR: lipid A had a sD of 1 to 2 ms. The molar
fraction of complexes in solution, F2, were 80.8% and 43.5%
for V4-TMR: LPS and V4-TMR: lipid A, respectively.
3.7. Binding of V4-TMR to SUVs of pure lipids
The interaction of V4-TMR (200 nM) with POPG, POPC,
POPE, DPPG, DPPC and DPPE was compared by studying
mixtures of V4-TMR with SUVs in PBS. The concentration of
lipids was in all cases 50 AM. A two-particle model was used
for data fitting, with the first diffusion time sD1 fixed to 52 As.
The values for the second particle, sD2, F2 and N2 are shown in
Fig. 6. The diffusion time of the larger particle sD2 was in all
cases between 0.6 and 1.7 ms, similar to the expected diffusion
time of lipid SUVs. However, F2 and N2 differed markedly
depending on the lipid used. In the group of lipids with
unsaturated lipid tails, the highest values for these parameters
Table 2
Comparison of interaction of V4-TMR peptide with LPS, lipid A and PC
C (kHz)a Napp sD1 [As] sD2 [ms] F2 [%] Q2/Q1b N2
V4-TMR 3.8T0.3 0.064T0.004 52.5T1.8 – – – –
V4-TMR:LPS 30.8T0.7 0.324T0.005 52.5c 1.08T0.07 80.8T0.2 1.73T0.28 0.270T0.004
V4-TMR:lipid A 11.2T1.3 0.095T0.009 52.5c 1.89T0.17 43.5T4.3 2.52T0.28 0.050T0.009
V4-TMR:PC 4.3T0.2 0.058T0.002 52.5c 1.87T2.59 4.2T1.2 3.21T0.37 0.003T0.001
a C is the overall count rate.
b Q1 is 59.5 kHz for free TMR.
c sD1 was fixed in data fitting.
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the differences were smaller but DPPG still showed the highest
F2 and N2.
3.8. Interaction of V4-TMR with mixed lipid SUVs
Gram-negative bacteria have a unique outer membrane,
which is negatively charged. Because of the similar net
negative charge of POPG, it is widely used to mimic theFig. 6. Comparison of V4-TMR binding to different SUVs. (A) F2 and (B) N2
indicate different binding affinity when V4-TMR binds to different lipid SUVs.
(C) Comparison of the diffusion time of SUVs bound by V4-TMR. All data
were fitted with a two-particle model. The diffusion time of the fast diffusing
particle (impurities of free TMR) was between 52 and 67 As. The slowly
diffusing particle (V4-TMR bound to SUVs) fell mostly in a range from 0.9 to
1.5 ms, as expected for the SUVs. The concentration of V4-TMR was 200 nM.
The total lipid concentration was 50 AM.bacterial outer membrane to study the interaction with
antimicrobial peptides. We thus used the mixture of POPE/
POPG=2/1 to mimic the bacterial outer membrane compared
to mixtures of POPC/POPE=3/1 mimicking mammalian
membranes (Fig. 7). In solutions of 200 nM V4-TMR and 50
AM of these lipid mixtures, the POPE/POPG SUVs showed a
similar ACF with that of pure POPG SUVs. The value of F2
and N2 were both very close to those of pure POPG SUVs,
although the mole fraction of POPG in the mixture lipid was
only 33%. However, POPC/POPE SUVs had smaller values of
F2 and N2 compared to POPG SUVs. The diffusion time of
V4-TMR: mixed lipids SUVs complex was similar to that of
pure lipids SUVs, between 0.6 and 1 ms.
3.9. Interaction of V4 with fluorophore entrapped LUVs
LUVs composed of POPG were used to investigate the
interaction of V4 with vesicles at a high peptide/lipid ratio.
Fig. 8 depicts the process of the leakage of fluorophore
entrapped LUVs (20 AM POPG lipid concentration) caused
by V4 (10 AM). The leakage occurred in less than 10 min.
At the beginning, the Rho 6G entrapped LUVs diffused as
large fluorescent particles, whose diffusion time was
6.46T2.56 ms (Fig. 8A). After less than 4-min incubation
with V4 two diffusion times could be detected. The two
fluorescent species in the solution have diffusion times of
47.2T4.2 As and 24.6T8.7 ms (Fig. 8B). After 8 min, thereFig. 7. Binding of V4-TMR to SUVs of mixed lipid composition. Shown are
autocorrelation functions of V4-TMR bound to SUVs made of either POPG o
mixtures of POPC/POPE (3:1) or POPE/POPG (2:1). The concentration of V4
TMR was 200 nM. The total lipid concentration was 50 AM. Fits to the data are
shown in solid lines.r
-
Fig. 8. Leakage of fluorophore entrapped LUVs (20 AM POPG lipid) was caused by V4 (10 AM) in less than 10 min. (A) At the beginning LUVs with Rho 6G
entrapped diffused as large fluorescent particle with a diffusion time on the order of 6 ms. (B) After less than 4 min, leakage occurred with some Rho 6G released into
the solution from vesicles. The free Rho 6G was detected as a particle with a diffusion time of 47.2T4.2 As. In addition, some large-size particles appeared in the
solution with long diffusion time of more than 20 ms. (C) After 8 min, only released Rho 6G can be detected with the diffusion time of 54.7T4.8 As. (D) Confocal
image of fluorophore labeled LUVs without peptide. (E) Confocal image of fluorophore labeled LUVs with peptide after 5 min.
L. Yu et al. / Biochimica et Biophysica Acta 1716 (2005) 29–3936was only one fluorescent species detected in the solution
with a diffusion time of 54.7T4.8 As (Fig. 8C). This value
compared well with the diffusion time of Rho 6G of
56.6T1.3 As, which indicated that the Rho 6G entrapped
inside the LUVs has been released into solution. Controls
with LUVs made of POPC (lipid concentration 20 AM) did
not show any obvious leakage up to a concentration of 10
AM V4.3.10. Interaction of V4 with fluorophore labeled LUVs
Initially 20 AM fluorophore labeled LUVs (lipid concentra-
tion) and 10 AM V4 were mixed. This led to a strong decrease
in photon count rates and large aggregates occasionally
appeared in the solution. We thus used confocal microscopy
to determine the fate of the vesicles. Without peptide, the
fluorophore labeled LUVs in solution were below the
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were seen as single spots. However, upon the addition of V4
into the solution followed by incubation of 5 min, obvious
large fluorescent aggregates appeared (Fig. 8E) with less
particles in solution.
4. Discussion
4.1. V4-TMR aggregates and is strongly quenched in PBS
V4-TMR solutions at 100 nM exhibit very low fluorescence
and ACFs with unexpectedly low number of particles and very
short diffusion times. A comparison of the ACF of 100 nM V4-
TMR with 1 nM TMR solution showed that the diffusion time
and fluorescence yield Q in the two solutions were similar. The
number of particles in the confocal volume for the V4-TMR
solution was 5 times lower than for free TMR despite its 100
times higher concentration. We thus suggest that the fluores-
cent particles seen in these solutions are actually free TMR and
the peptide itself is quenched and cannot be detected, except
for rare isolated peaks. Comparing the numbers of particles
detected in the two solutions, the proposed impurity of free
TMR in V4-TMR solution would be 0.18%, which is well
within the limits of the manufacturer. The intensity of V4-TMR
on the coverslip surface and in solution from confocal imaging
confirmed the result (Table 1). The fluorescence intensity of 5
AM V4-TMR is much lower than that of 100 nM TMR both on
coverslip and in solution. Assuming that there is 0.18%
impurity of TMR in the V4-TMR solution, a concentration of
9 nM free TMR will be expected. Thus the 100 nM TMR
solution has a 100/911 times higher TMR concentration.
Comparing the surface fluorescence of the 100 nM TMR to the
5 AM V4-TMR shows that the surface peak is about 3432/
30611 times higher, which implies that most fluorescence
seen on the surface stems from free TMR.
The rare occurrence of large count rate peaks in the solution
together with the results from titrating V4 with R18, where
large, slow diffusing fluorescent peaks were seen, point
towards peptide aggregation. The aggregation is a consequence
of the strong hydrophobicity of the peptide and leads to self-
quenching of the fluorophores. However, the multiple positive
charges on the peptide should act against aggregation. To test
this hypothesis, we made FCS measurements of V4-TMR in
de-ionized water. In contrast to PBS the lack of ions which
shield electrostatic interactions should lead to a decrease in
aggregation and of self-quenching. This was found to be the
case and in pure water the measured number of particles of V4-
TMR in the confocal volume rose and a larger number of
smaller aggregates were seen. However, the peptide was still
not completely dissolved. Similarly, attempts to dissolve the
peptide in the detergent Triton-X100 or DMSO failed.
Therefore, we suggest that the peptide in PBS is strongly
quenched due to aggregation and only free TMR impurities can
be detected in FCS.
This opens the possibility that quenched aggregated V4-
TMR attached to the coverslip and escaped detection in the
confocal studies. However, the confocal study in the presenceof LPS shows that even if aggregated V4-TMR should have
attached to the coverslip, only a small part of this attached V4-
TMR can be activated and the increase of the fluorescence, as
expected during V4-TMR: LPS binding (Table 2), is on the
same order of magnitude as the fluorescence increase in
solution (Table 1).
4.2. LPS and lipids can partly dissolve V4
When V4-TMR at constant concentration was titrated with
increasing concentration of LPS or lipids, the photon count
rates of the mixture and the apparent number of particles
detected both increased (Figs. 4 and 5). It should be noted that
the increases were strongest for lipids which are supposed to
have a high affinity for V4 based on their negative charge.
Hence, LPS and POPG showed strong increases due to the
putative electrostatic interactions while the other lipids and
lipid mixtures showed smaller changes. This can be explained
by two effects: (i) The interaction of V4-TMR with LPS or
lipids leads to a disaggregation of V4-TMR aggregates which
previously existed due to the strong hydrophobicity of the
peptide and in which TMR is strongly quenched; in other
words, the V4-TMR peptide was solubilised by LPS or lipids.
The disaggregation thus leads to an increase in fluorescence as
well as an apparent increase in the number of particles
observed. It should be noted however, that none of the lipids
can dissolve the peptide completely. A comparison of N
detected in the case of saturated binding (100 nM V4, 10 AM
LPS, N2 =NF2 = 0.270) with a 1 nM TMR solution
(N =0.349) indicates that less than 0.77% of the peptide is
dissolved. ii) TMR, the fluorescent label attached to V4, comes
into a different local environment upon binding (local pH,
polarity) leading to an increase in its fluorescence yield Q.
Both effects will lead to an increase in the number of particles
N and an increase in photon count rates as observed. From the
data we have estimated Q for the V4-TMR: LPS and V4-TMR:
lipid A complex in its hydrophobic environment to be about
twice as bright as free TMR in aqueous solution (Table 2). This
change in fluorescence yield is an effect of the local
environment of the fluorophore and cannot be attributed to
multiple peptides binding to one vesicle or micelle since at the
low concentrations of V4-TMR used compared to the lipid
concentrations, it is unlikely to find more than one peptide
bound per lipid complex.
Experiments with FITC-LPS support this hypothesis of
peptide disaggregation. In these measurements no changes in
diffusion time or the number of particles could be detected,
indicating that (i) V4 does not disaggregate LPS micelles as has
been shown for other antimicrobial peptides [38], and (ii) none
of the large V4 aggregates detected in the titration experiment
with R18 are binding to LPS. This indicates that the peptide is
actually disaggregated when binding to LPS or lipids.
Therefore, to increase the fraction of peptide that is active,
the peptide should be redesigned by embedding the binding
pattern in a more hydrophilic or amphipathic structure to
increase the solubility and facilitate the disaggregation of the
peptide by LPS and bacterial membrane-like lipids.
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It has been suggested that electrostatic and hydrophobic
interactions are predominant forces driving the binding process
between antimicrobial peptides and membranes [20]. V4 is a
very hydrophobic peptide with 8 valines among 19 residues.
The high hydrophobicity gives the peptide a tendency to self-
aggregate and to interact with alkyl chains of LPS and other
lipids. Besides its predominant hydrophobic nature, its highly
positive charge with 4 lysines helps in interacting with the
phosphate groups of the lipid A moiety of LPS and lipids with
negative charge, such as POPG and DPPG. The importance of
electrostatic interactions in comparison to hydrophobic inter-
actions can be seen from the experiments. Despite having the
same lipid tail groups the affinity of V4-TMR was higher for
POPG, an anionic lipid, than for POPC and POPE, both
zwitterionic lipids. This indicates that electrostatic interaction
is the major driving force for the binding process. DPPG,
DPPE and DPPC also showed the same results in pure lipid
SUVs. In the mixed lipids POPG/POPE, although the fraction
of POPG was only 33%, the binding efficiency was almost the
same as that of pure POPG. The strong binding of V4-TMR to
negative lipids vesicles was the reason for the selectivity of the
peptide for bacterial membranes in contrast to mammalian
membranes. The structural integrity of the LPS molecules was
significant in the binding process. The results showed that the
full, intact LPS molecule is needed for maximal binding
affinity. The binding efficiency of V4-TMR with lipid A was
lower than that of LPS despite the fact that lipid A is
considered to be the bioactive part of LPS.
4.4. Saturation of lipids affects the binding with V4-TMR
The affinity of V4-TMR for lipids SUVs with the same head
group was always larger for unsaturated lipids (POPG, POPE,
POPC) than for saturated lipids (DPPG, DPPE, DPPC) as
shown in Fig. 6B. The double bond of the unsaturated lipids
increases the fluidity of the lipid bilayer, leading to less dense
packing of the unsaturated lipid molecules. This provides V4-
TMR better access to the unsaturated lipid molecules and
increases the chance of insertion into the bilayer. In addition,
the interaction between V4-TMR and the lipid tail groups is
facilitated for the unsaturated lipids due to the larger flexibility
of the tail groups [39]. Both effects, the packing of lipid
molecule in the bilayer, and the flexibility of the tail groups,
could contribute to the higher binding affinity of V4-TMR for
unsaturated lipids.
4.5. The mechanism of interaction between V4 and lipid
vesicles
Although V4 can bind LPS, lipid A and other artificial lipids
at a very low peptide/lipid ratio, the leakage of vesicles in the
presence of V4 can only be observed at a higher peptide/lipid
ratio. Considering that the large peptide aggregates are not
active and only about 0.77% of the peptide is active, leakage
was observed at a peptide/lipid ratio of 1:260. The diameter ofLUVs is around 100 nm and the area of each lipid molecule is
0.4 nm2 [41], therefore the ratio of peptide to LUVs is
estimated to be 606:1. When the concentration of peptide
decreased to a ratio of 1:2600 (peptide/LUVs=61:1), there was
no observable leakage. Compared to V4-TMR binding to
different lipid SUVs, the peptide/SUVs is about 1.2:1 which is
much lower and more peptide is needed to make the vesicles
permeable. Confocal imaging showed that POPG LUVs fused
within 5 min. Since these large aggregates were relatively few
in number, they were observed in only some of the FCS
measurements if at all. The results from confocal imaging were
consistent with the interpretation of leakage and fusion of
vesicles. V4 might first bind to the surface of the vesicles
through electrostatic interactions with the hydrophilic head-
group of the lipids. Conformational changes of the peptide
could then cause the hydrophobic part of the peptide to interact
with the alkyl chains of the lipids by a strengthened
hydrophobic interaction. When a threshold concentration of
V4 is reached, the lipid membrane is disrupted and becomes
permeable. At the same time V4, which has two hydrophobic
arms, might act as a linker between vesicle fragments and thus
lead to lipid vesicles aggregation forming the large particles
shown in Fig. 8D and E.
5. Conclusion
Antimicrobial peptides have elicited great interest due to
their potential clinical use. In this paper we applied fluores-
cence correlation spectroscopy to investigate the action of a
rationally designed antimicrobial peptide V4. We have shown
for the first time, to our knowledge, that a simple amphipathic
cationic pattern BHBHB in a cyclized structure is sufficient to
impart selectivity and antimicrobial activity. V4 was shown to
bind selectively to negatively charged lipids, typically found in
bacteria. At a peptide/lipid ratio of 1:260 (peptide/
LUVs=606:1) this peptide can render large unilamellar
vesicles permeable and cause vesicle fusion. Considering that
only less than 1% of the peptide is active, the antimicrobial
activity is expected to increase greatly if the peptide solubility
can be increased. Therefore it is necessary to design a peptide
containing the identified binding patterns but in a more
hydrophilic or detergent-like structure which would increases
solubility and possibly the activity of the peptide.
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